Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars ØStergaard

Showing results (201-210 of 279) with videos related to

Pageof 28
Sort By:
Frontiers in Immunology|October 17, 2019
Distinct Autoimmune Anti-α-Synuclein Antibody Patterns in Multiple System Atrophy and Parkinson's DiseaseJonas Folke, Rasmus Rydbirk, Annemette Løkkegaard, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 8, 2011
Tenofovir selectively regulates production of inflammatory cytokines and shifts the IL-12/IL-10 balance in human primary cellsJesper Melchjorsen, Michael W Risør, Ole S Søgaard, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 22, 2014
Interobserver variation of the rapid test SD bioline HIV-1/2 3.0 for HIV type discrimination: experiences from Guinea-BissauBo Langhoff Hønge, Sanne Jespersen, Magnús P Bjarnason Obinah, et al.
Infectious Diseases (London, England)|March 3, 2026
Procalcitonin compared to C-reactive protein and leukocyte count. A comparative analysis of baseline markers of bacterial co-infection in patients admitted with a viral respiratory tract infection. A retrospective observational cohort studyBo Langhoff Hønge, Jacob Rudjord Therkilsen, Jacob Redder, et al.
Tropical Medicine & International Health : TM & IH|December 1, 2015
Differential effects of sex in a West African cohort of HIV-1, HIV-2 and HIV-1/2 dually infected patients: men are worse offSanne Jespersen, Bo Langhoff Hønge, Joakim Esbjörnsson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 26, 2018
Protease Inhibitors or NNRTIs as First-Line HIV-1 Treatment in West Africa (PIONA): A Randomized Controlled TrialSanne Jespersen, Bo Langhoff Hønge, Henrik Krarup, et al.
Antimicrobial Agents and Chemotherapy|April 22, 2015
Histone deacetylase inhibitor romidepsin inhibits de novo HIV-1 infectionsKasper L Jønsson, Martin Tolstrup, Johan Vad-Nielsen, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 17, 2014
Hepatitis C prevalence among HIV-infected patients in Guinea-Bissau: a descriptive cross-sectional studyBo Langhoff Hønge, Sanne Jespersen, Candida Medina, et al.
Bulletin of the World Health Organization|January 2, 2015
Challenges facing HIV treatment in Guinea-Bissau: the benefits of international research collaborationsSanne Jespersen, Bo Langhoff Hønge, Inés Oliveira, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|April 15, 2016
Diabetes mellitus and impaired fasting glucose in ART-naïve patients with HIV-1, HIV-2 and HIV-1/2 dual infection in Guinea-Bissau: a cross-sectional studyDitte Steiniche, Sanne Jespersen, Christian Erikstrup, et al.
Pageof 28

Showing results (201-210 of 279) with videos related to

Sort By:
Pageof 28
Frontiers in Immunology|October 17, 2019
Distinct Autoimmune Anti-α-Synuclein Antibody Patterns in Multiple System Atrophy and Parkinson's DiseaseJonas Folke, Rasmus Rydbirk, Annemette Løkkegaard, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 8, 2011
Tenofovir selectively regulates production of inflammatory cytokines and shifts the IL-12/IL-10 balance in human primary cellsJesper Melchjorsen, Michael W Risør, Ole S Søgaard, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 22, 2014
Interobserver variation of the rapid test SD bioline HIV-1/2 3.0 for HIV type discrimination: experiences from Guinea-BissauBo Langhoff Hønge, Sanne Jespersen, Magnús P Bjarnason Obinah, et al.
Infectious Diseases (London, England)|March 3, 2026
Procalcitonin compared to C-reactive protein and leukocyte count. A comparative analysis of baseline markers of bacterial co-infection in patients admitted with a viral respiratory tract infection. A retrospective observational cohort studyBo Langhoff Hønge, Jacob Rudjord Therkilsen, Jacob Redder, et al.
Tropical Medicine & International Health : TM & IH|December 1, 2015
Differential effects of sex in a West African cohort of HIV-1, HIV-2 and HIV-1/2 dually infected patients: men are worse offSanne Jespersen, Bo Langhoff Hønge, Joakim Esbjörnsson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 26, 2018
Protease Inhibitors or NNRTIs as First-Line HIV-1 Treatment in West Africa (PIONA): A Randomized Controlled TrialSanne Jespersen, Bo Langhoff Hønge, Henrik Krarup, et al.
Antimicrobial Agents and Chemotherapy|April 22, 2015
Histone deacetylase inhibitor romidepsin inhibits de novo HIV-1 infectionsKasper L Jønsson, Martin Tolstrup, Johan Vad-Nielsen, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 17, 2014
Hepatitis C prevalence among HIV-infected patients in Guinea-Bissau: a descriptive cross-sectional studyBo Langhoff Hønge, Sanne Jespersen, Candida Medina, et al.
Bulletin of the World Health Organization|January 2, 2015
Challenges facing HIV treatment in Guinea-Bissau: the benefits of international research collaborationsSanne Jespersen, Bo Langhoff Hønge, Inés Oliveira, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|April 15, 2016
Diabetes mellitus and impaired fasting glucose in ART-naïve patients with HIV-1, HIV-2 and HIV-1/2 dual infection in Guinea-Bissau: a cross-sectional studyDitte Steiniche, Sanne Jespersen, Christian Erikstrup, et al.
Pageof 28